Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Jesus G, Romero"'
Autor:
Yash Gupta, Neha Sharma, Snigdha Singh, Jesus G. Romero, Vinoth Rajendran, Reagan M. Mogire, Mohammad Kashif, Jordan Beach, Walter Jeske, Poonam, Bernhards R. Ogutu, Stefan M. Kanzok, Hoseah M. Akala, Jennifer Legac, Philip J. Rosenthal, David J. Rademacher, Ravi Durvasula, Agam P. Singh, Brijesh Rathi, Prakasha Kempaiah
Publikováno v:
Pharmaceutics, Vol 14, Iss 7, p 1371 (2022)
Malaria elimination urgently needs novel antimalarial therapies that transcend resistance, toxicity, and high costs. Our multicentric international collaborative team focuses on developing multistage antimalarials that exhibit novel mechanisms of act
Externí odkaz:
https://doaj.org/article/51f533a3d8a647a8b2b71052ec3441fa
Autor:
Yash, Gupta, Steven, Goicoechea, Jesus G, Romero, Raman, Mathur, Thomas R, Caulfield, Daniel P, Becker, Ravi, Durvasula, Prakasha, Kempaiah
Publikováno v:
Journal of Food and Drug Analysis. 30:129-150
Leishmaniasis remains a serious public health problem in many tropical regions of the world. Among neglected tropical diseases, the mortality rate of leishmaniasis is second only to malaria. All currently approved therapeutics have toxic side effects
Autor:
Matthew C Weyenberg, Ravi Durvasula, Stefan M. Kanzok, Poonam, Catherine M. Pearce, Neha Sharma, Jesus G Romero, Raman Mathur, Steven Goicoechea, Brijesh Rathi, Prakasha Kempaiah, Yash Gupta, Hoseah M. Akala, Bharathi Daravath, Samuel K. Kwofie
Publikováno v:
Medicinal Research Reviews. 42:56-82
Calcium channels (CCs), a group of ubiquitously expressed membrane proteins, are involved in many pathophysiological processes of protozoan parasites. Our understanding of CCs in cell signaling, organelle function, cellular homeostasis, and cell cycl
Autor:
Yash Gupta, Neha Sharma, Snigdha Singh, Jesus G. Romero, Vinoth Rajendran, Reagan M. Mogire, Raman Mathur, Mohammad Kashif, Jordan Beach, Walter Jeske, Poonam, Bernhards Ogutu, Stefan M. Kanzok, Hoseah M. Akala, Jennifer Legac, Philip J. Rosenthal, David J. Rademacher, Ravi Durvasula, Agam P. Singh, Brijesh Rathi, Prakasha Kempaiah
Publikováno v:
SSRN Electronic Journal.
Autor:
Jean-Yves Blay, Claudia Sangalli, Angelo Paolo Dei Tos, Alessandro Gronchi, Cleofe Romagosa, Rosa Alvarez, Jesus G. Romero, Nadia Hindi, Marie Pierre Sunyach, Josefina Cruz, Javier Martin-Broto, Roberta Sanfilippo, Antoine Italiano, Inmaculada Rincón, Antonio Lopez-Pousa, Carlo Morosi, Antonio Gutierrez, Jose Luis Pérez Aguiar, Paolo G. Casali, Dominique Ranchère-Vince
Publikováno v:
EClinicalMedicine
Background Myxoid liposarcoma (ML) exhibits a special sensitivity to trabectedin (T) and radiation therapy (RT). Preclinical data suggest a synergistic effect. We aimed to study safety, feasibility and activity of the administration of pre-operative
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8bcf3878dfb601b12f525f87607afc30
https://doi.org/10.1016/j.eclinm.2019.03.007
https://doi.org/10.1016/j.eclinm.2019.03.007
Autor:
Roberta Sanfilippo, Carlo Morosi, Pablo Luna Fra, Andrés Redondo, Paolo De Tos, Jean-Yves Blay, Javier Martinez-Trufero, Claudia Sangalli, Cleofé Romagosa, Josefina Cruz Jurado, Javier Peinado, Claudia Maria Valverde Morales, Marie Pierre Sunyach, Jesus G. Romero, Nadia Hindi, Antonio Gutierrez, Javier Martin Broto, Dominique Ranchère-Vince, Alessandro Gronchi
Publikováno v:
Journal of Clinical Oncology. 38:11514-11514
11514 Background: Myxoid liposarcoma (ML) exhibits especial sensitivity to trabectedin (T). In prospective series, T showed responses in 44% of patients (pts) with ML. ML is also sensitive to radiation therapy (RT) and preclinical data suggested radi
Autor:
Alejandro Mata, Jesus G. Romero
Publikováno v:
Biophysical Journal. 118:271a
Publikováno v:
Biophysical Journal. 116:241a-242a
Autor:
Jesus G. Romero, Carlo Morosi, Ana Alvarez, Ignacio Alastuey, Josep Isern, Marie-Pierre Sunyach, Rosa Alvarez, Nadia Hindi, Giovanni Grignani, Inmaculada Rincón, Jean-Yves Blay, Maria Carmen Dolado, Javier Martin Broto, Pablo Luna Fra, Marco Gatti, Antonio Lopez-Pousa, Javier Peinado, Alessandro Gronchi, Josefina Cruz
Publikováno v:
Journal of Clinical Oncology. 36:11544-11544
11544Background: Patients (pts) with advanced STS who require tumor shrinkage beyond first line, have very limited options since the approved drugs exhibit less than 10% of RECIST response. Trabect...
Publikováno v:
Biophysical Journal. 114:491a